| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/30/2008 | CN101167754A Application of sea bone peptide in preparing medicine, health-care food or food for preventing osteoporosis |
| 04/30/2008 | CN101167738A Application of montmorillonite and composition containing montmorillonite in preparing medicine for treating hyperuricemia and gout |
| 04/30/2008 | CN101167694A Bath article and its preparation method |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384462C Medicinal composition for treating acute urarthritis and its preparation method |
| 04/30/2008 | CN100384446C Medicine emplastrum for treating osteoproliferation and its preparing method |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365153 Biologically active peptide and agent containing the same |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365052 Tendon-inducing methods |
| 04/29/2008 | US7364887 Osteoarthritis; rheumatic diseases; antiarthritic agents |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | CA2406798C Pharmaceutical parenteral composition containing a biphosphonate |
| 04/29/2008 | CA2363317C Novel process for preparing alendronic acid |
| 04/29/2008 | CA2309178C Topical compositions for nsai drug delivery |
| 04/29/2008 | CA2294756C Cross-linked polysaccharide drug carrier |
| 04/24/2008 | WO2008048784A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | WO2008047880A1 Therapeutic agent for rheumatoid arthritis |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008011080A3 Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096927 Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096918 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096872 Composition for Treatment of Pain Specification |
| 04/24/2008 | US20080096851 (20S)-1Alpha-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and Its Uses |
| 04/24/2008 | US20080096841 Using analogs of Lipid A such as Eritoran to treat or prevent mucositis, allograft/graft rejection, arteriosclerosis, atherosclerosis, hepatitis, asthma, and inflammatory bowel disease |
| 04/24/2008 | US20080096825 Preparation and Use of Phlorizin Compositions |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2672907A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1913940A1 Rhein conjugates, preparation method thereof and their uses in producing medicines for treating diabetic nephrosis, intestinal adhesion and osteoarthritis |
| 04/23/2008 | EP1913131A2 Method for isolating stem cells and stem cells derived from a pad-like tissue |
| 04/23/2008 | EP1913028A2 Use of antibody to m-csf |
| 04/23/2008 | EP1913027A2 M-csf specific monoclonal antibody and uses thereof |
| 04/23/2008 | EP1912977A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1912971A2 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 04/23/2008 | EP1912964A2 Dihydroxyanthraquinones and their use |
| 04/23/2008 | EP1912945A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
| 04/23/2008 | EP1912941A1 Novel piperidine derivatives |
| 04/23/2008 | EP1912654A2 Methods for selectively treating cox-2 mediated disorders by administering gamma-tocopherol |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166519A Dosage forms of risedronate |
| 04/23/2008 | CN101164610A Blood-circulation and removing blood stasis ointment |
| 04/23/2008 | CN101164604A Traditional Chinese medicine for treating arthrosis and preparing method thereof |
| 04/23/2008 | CN101164597A Traditional Chinese medicine for treating infantile rickets |
| 04/23/2008 | CN101164591A Wind-expelling dampness-removing medicinal composition and preparation method and use thereof |
| 04/23/2008 | CN101164585A Medicine for curing gout and its preparing method |
| 04/23/2008 | CN101164568A External-applied traditional Chinese medicine for treating hyperosteogeny |
| 04/23/2008 | CN101164556A Musk ointment for treating osteopathy |
| 04/23/2008 | CN101164536A Apigenin vesicle preparation and its preparation technology |
| 04/23/2008 | CN100383523C Method for controlling quality of medicine composition for curing traumatic injury |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100382842C Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 04/23/2008 | CN100382838C Chinese medicine for treating blood stagnation disease and preparation method thereof |
| 04/23/2008 | CN100382817C Collateral channels clearing arthralgia dredging prescription for treating rheumatoid arthritis and its preparing process |
| 04/23/2008 | CN100382815C Compound composition for treating arthralgia caused by wind-dampness and preparation thereof |
| 04/23/2008 | CN100382809C Medicinal wine for traumatic injury and its preparation method |
| 04/23/2008 | CN100382781C Method for preparing bath powder of Tibet medicine and its quality control method |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361195 Cartilage repair apparatus and method |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045461A2 Transdermal diethylstilbestrol for treating prostate cancer |
| 04/17/2008 | WO2008044785A1 Material for improvement of cerebral blood flow, and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044731A1 N-phenyloxamidic acid derivative |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |